MD, PhD consultant with broad clinical drug development (phase 1-4) and regulatory experience (FDA, EMA and PMDA) from large pharma and biotech.
Specific experience within the metabolic (diabetes, lipids, NAFLD/NASH) and cardiovascular therapy areas (atherosclerosis, heart failure, arrhythmia).
See my LinkedIn profile for more information.
Strong scientific background with PhD + PostDoc and more than 100 publications in leading journals (>10,000 citations, h-index = 46). See publications here.
Clinical background within internal medicine and cardiology.